Update: New England Journal of Medicine publishes correction to 2012 CHEST trial of hydroxyethyl starch versus colloidsBMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i1571 (Published 21 March 2016) Cite this as: BMJ 2016;352:i1571
- Peter Doshi, associate editor
- The BMJ, London WC1H 9JR, UK
After publication of my article,1 the New England Journal of Medicine (NEJM) published a correction to the 2012 CHEST trial of hydroxyethyl starch versus colloids.2 3 A new P value of 0.006 was provided for the comparison of treatment related adverse events between hydroxyethyl starch (HES) and saline groups (180/3871 (4.6%) v 95/2870 (3.3%)). Before the correction, this was reported as 180/3416 (5.3%) …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial